Press release -

Atherosclerosis vaccine study wins VINNOVA grant

Athera Biotechnologies has been granted support from the Swedish Governmental Agency for Innovation Systems, VINNOVA, for a pre-study to investigate a new approach with vaccination to prevent atherosclerosis.

Three hundred companies had applied for the current call to the Research&Growth program to a total amount of SEK 440 million. VINNOVA has today announced the 49 companies of these 300 which are supported with in total SEK 50 million. Athera Biotechnologies is among the seven grant winners who are involved in the life science industry.

Through the Research&Growth program, VINNOVA finances research and development projects in small companies. Companies can apply for support for research and development projects, pre clinical trials or necessity identification before research and development projects.

Topics

  • Health, Health Care, Pharmaceuticals

Categories

  • athera biotechnologies
  • athera
  • atherosclerosis
  • läkemedel

Contacts

Related media

Related content

Enter your email address to follow Athera Biotechnologies AB

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Athera Biotechnologies AB.

Okay